# Efficacy of Potassium Sodium Hydrogen Citrate Therapy on Renal Stone Recurrence and/or Residual Fragments After Shockwave Lithotripsy and Percutaneous Nephrolithotomy in Calcium Oxalate Urolithiasis

> **NCT01329042** · PHASE4 · COMPLETED · sponsor: **Ouiheng International Healthcare Co., Ltd** · enrollment: 80 (actual)

## Conditions studied

- Kidney Calculi

## Interventions

- **DRUG:** Potassium-sodium citrate

## Key facts

- **NCT ID:** NCT01329042
- **Lead sponsor:** Ouiheng International Healthcare Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2007-10
- **Final completion:** 2008-02
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2011-04-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01329042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01329042, "Efficacy of Potassium Sodium Hydrogen Citrate Therapy on Renal Stone Recurrence and/or Residual Fragments After Shockwave Lithotripsy and Percutaneous Nephrolithotomy in Calcium Oxalate Urolithiasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01329042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*